Schizophrenia Symptom Management

Basic qualifications:
  • Male or female
  • 13 - 65 years old
  • Have a diagnosis of schizophrenia
  • Have a history of at least 1 relapse in the last 2 years

This study will evaluate the long term safety and tolerability of an injectable investigational medication for the treatment of chronic schizophrenia symptoms. All study-related visits, exams, and study drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided.


To find out more click here.